Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
Merck
Baxter
Fish and Richardson
Covington
Moodys
Argus Health
Medtronic

Generated: April 25, 2018

DrugPatentWatch Database Preview

LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE Drug Profile

« Back to Dashboard

When do Loperamide Hydrochloride And Simethicone patents expire, and what generic alternatives are available?

Loperamide Hydrochloride And Simethicone is a drug marketed by Perrigo and Sun Pharm Inds Ltd and is included in two NDAs.

The generic ingredient in LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.
Summary for LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE
Drug patent expirations by year for LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE
Synonyms for LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE
137524-29-9
Imodium advance
IMODIUM ADVANCED
Imodium Multi-Symptom Relief
Loperamide / simethicone
Loperamide / simeticone
Loperamide and simethicone
Loperamide HCl mixture with simethicone
Loperamide hydrochloride mixture with simethicone

US Patents and Regulatory Information for LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET, CHEWABLE;ORAL 076029-001 Aug 30, 2002 OTC No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Ltd LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET;ORAL 077500-001 Sep 6, 2006 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
QuintilesIMS
Boehringer Ingelheim
Federal Trade Commission
Moodys
US Department of Justice
Citi
Cerilliant
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.